188 related articles for article (PubMed ID: 26589287)
21. Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation.
Jang JH; Rickenbacher A; Humar B; Weber A; Raptis DA; Lehmann K; Stieger B; Moritz W; Soll C; Georgiev P; Fischer D; Laczko E; Graf R; Clavien PA
Hepatology; 2012 Jul; 56(1):209-18. PubMed ID: 22290718
[TBL] [Abstract][Full Text] [Related]
22. Beneficial effect of docosahexaenoic acid on cholestatic liver injury in rats.
Chen WY; Lin SY; Pan HC; Liao SL; Chuang YH; Yen YJ; Lin SY; Chen CJ
J Nutr Biochem; 2012 Mar; 23(3):252-64. PubMed ID: 21497498
[TBL] [Abstract][Full Text] [Related]
23. Conditional loss of heparin-binding EGF-like growth factor results in enhanced liver fibrosis after bile duct ligation in mice.
Takemura T; Yoshida Y; Kiso S; Kizu T; Furuta K; Ezaki H; Hamano M; Egawa M; Chatani N; Kamada Y; Imai Y; Higashiyama S; Iwamoto R; Mekada E; Takehara T
Biochem Biophys Res Commun; 2013 Jul; 437(2):185-91. PubMed ID: 23743191
[TBL] [Abstract][Full Text] [Related]
24. Bile duct ligation in mice: induction of inflammatory liver injury and fibrosis by obstructive cholestasis.
Tag CG; Sauer-Lehnen S; Weiskirchen S; Borkham-Kamphorst E; Tolba RH; Tacke F; Weiskirchen R
J Vis Exp; 2015 Feb; (96):. PubMed ID: 25741630
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic effects of antigen affinity-purified polyclonal anti-receptor of advanced glycation end-product (RAGE) antibodies on cholestasis-induced liver injury in rats.
Xia P; Deng Q; Gao J; Yu X; Zhang Y; Li J; Guan W; Hu J; Tan Q; Zhou L; Han W; Yuan Y; Yu Y
Eur J Pharmacol; 2016 May; 779():102-10. PubMed ID: 26970185
[TBL] [Abstract][Full Text] [Related]
26. The protective role of natural phytoalexin resveratrol on inflammation, fibrosis and regeneration in cholestatic liver injury.
Chan CC; Cheng LY; Lin CL; Huang YH; Lin HC; Lee FY
Mol Nutr Food Res; 2011 Dec; 55(12):1841-9. PubMed ID: 22086758
[TBL] [Abstract][Full Text] [Related]
27. Gene expression profiling in whole liver of bile duct ligated rats: VEGF-A expression is up-regulated in hepatocytes adjacent to the portal tracts.
Tanaka A; Tsuneyama K; Mikami M; Uegaki S; Aiso M; Takikawa H
J Gastroenterol Hepatol; 2007 Nov; 22(11):1993-2000. PubMed ID: 17914982
[TBL] [Abstract][Full Text] [Related]
28. Aqueous extract of Artemisia iwayomogi Kitamura attenuates cholestatic liver fibrosis in a rat model of bile duct ligation.
Han JM; Kim HG; Choi MK; Lee JS; Park HJ; Wang JH; Lee JS; Son SW; Hwang SY; Son CG
Food Chem Toxicol; 2012 Oct; 50(10):3505-13. PubMed ID: 22824087
[TBL] [Abstract][Full Text] [Related]
29. Cholestatic liver injury increases circulating TNF-alpha and IL-6 and mortality after Escherichia coli endotoxemia.
Lechner AJ; Velasquez A; Knudsen KR; Johanns CA; Tracy TF; Matuschak GM
Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1550-8. PubMed ID: 9603137
[TBL] [Abstract][Full Text] [Related]
30. Protective effect of gastrodin on bile duct ligation-induced hepatic fibrosis in rats.
Zhao S; Li N; Zhen Y; Ge M; Li Y; Yu B; He H; Shao RG
Food Chem Toxicol; 2015 Dec; 86():202-7. PubMed ID: 26498411
[TBL] [Abstract][Full Text] [Related]
31. Dexamethasone decreases cholestatic liver injury via inhibition of intrinsic pathway with simultaneous enhancement of mitochondrial biogenesis.
Tiao MM; Lin TK; Chen JB; Liou CW; Wang PW; Huang CC; Chou YM; Huang YH; Chuang JH
Steroids; 2011 Jun; 76(7):660-6. PubMed ID: 21419148
[TBL] [Abstract][Full Text] [Related]
32. Osteodystrophy in Cholestatic Liver Diseases Is Attenuated by Anti-γ-Glutamyl Transpeptidase Antibody.
Kawazoe Y; Miyauchi M; Nagasaki A; Furusho H; Yanagisawa S; Chanbora C; Inubushi T; Hyogo H; Nakamoto T; Suzuki K; Moriwaki S; Tazuma S; Niida S; Takata T
PLoS One; 2015; 10(9):e0139620. PubMed ID: 26418133
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type I ductular reaction in mice: interactions between the periductal inflammatory and stromal cells and the biliary epithelium.
Liu Z; Sakamoto T; Ezure T; Yokomuro S; Murase N; Michalopoulos G; Demetris AJ
Hepatology; 1998 Nov; 28(5):1260-8. PubMed ID: 9794910
[TBL] [Abstract][Full Text] [Related]
34. LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice.
Isayama F; Hines IN; Kremer M; Milton RJ; Byrd CL; Perry AW; McKim SE; Parsons C; Rippe RA; Wheeler MD
Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1318-28. PubMed ID: 16439470
[TBL] [Abstract][Full Text] [Related]
35. The pathophysiology of human obstructive cholestasis is mimicked in cholestatic Gold Syrian hamsters.
van Golen RF; Olthof PB; de Haan LR; Coelen RJ; Pechlivanis A; de Keijzer MJ; Weijer R; de Waart DR; van Kuilenburg ABP; Roelofsen J; Gilijamse PW; Maas MA; Lewis MR; Nicholson JK; Verheij J; Heger M
Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):942-951. PubMed ID: 29196240
[TBL] [Abstract][Full Text] [Related]
36. Differential regulation of hepatic transporters in the absence of tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and nuclear factor-kappaB in two models of cholestasis.
Lickteig AJ; Slitt AL; Arkan MC; Karin M; Cherrington NJ
Drug Metab Dispos; 2007 Mar; 35(3):402-9. PubMed ID: 17151194
[TBL] [Abstract][Full Text] [Related]
37. Targeting endothelial coagulation signaling ameliorates liver obstructive cholestasis and dysfunctional angiogenesis.
Yang X; Ou Y; Yang Y; Wang L; Zhang Y; Zhao F; Shui P; Qing J
Exp Biol Med (Maywood); 2023 Jul; 248(14):1242-1253. PubMed ID: 37644866
[TBL] [Abstract][Full Text] [Related]
38. Complement factor C5 deficiency significantly delays the progression of biliary fibrosis in bile duct-ligated mice.
Schmitt J; Roderfeld M; Sabrane K; Zhang P; Tian Y; Mertens JC; Frei P; Stieger B; Weber A; Müllhaupt B; Roeb E; Geier A
Biochem Biophys Res Commun; 2012 Feb; 418(3):445-50. PubMed ID: 22277671
[TBL] [Abstract][Full Text] [Related]
39. Gene transfer of IGF1 attenuates hepatocellular apoptosis after bile duct ligation.
Pi-Chieh Wang K; Lee LM; Lin TJ; Sheen-Chen SM; Lin JW; Chiu WT; Wang CC; Hung KS
J Surg Res; 2011 May; 167(2):237-44. PubMed ID: 19926099
[TBL] [Abstract][Full Text] [Related]
40. Critical role of plasminogen activator inhibitor-1 in cholestatic liver injury and fibrosis.
Bergheim I; Guo L; Davis MA; Duveau I; Arteel GE
J Pharmacol Exp Ther; 2006 Feb; 316(2):592-600. PubMed ID: 16221737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
